XTX Topco Ltd Increases Stake in Haleon PLC Sponsored ADR (NYSE:HLN)

Key Points

• XTX Topco Ltd increased its stake in Haleon PLC by 33.4%, purchasing an additional 49,897 shares during the first quarter, bringing its total holdings to 199,348 shares.
• Several hedge funds, including Bartlett & CO. Wealth Management and Opal Wealth Advisors, made significant changes to their positions in Haleon during the first quarter, indicating increased institutional interest.
• Analysts have mixed ratings on Haleon, with Morgan Stanley upgrading its rating to "overweight" and a consensus average price target of $12.33.

XTX Topco Ltd boosted its stake in Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) by 33.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 199,348 shares of the company's stock after purchasing an additional 49,897 shares during the period. XTX Topco Ltd's holdings in Haleon were worth $2,051,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in HLN. FMR LLC raised its stake in shares of Haleon by 3.7% during the fourth quarter. FMR LLC now owns 108,827,814 shares of the company's stock valued at $1,038,217,000 after acquiring an additional 3,909,545 shares during the last quarter. Wellington Management Group LLP grew its holdings in shares of Haleon by 67.5% during the fourth quarter. Wellington Management Group LLP now owns 15,328,325 shares of the company's stock valued at $146,232,000 after buying an additional 6,175,835 shares during the last quarter. Envestnet Asset Management Inc. boosted its holdings in Haleon by 0.8% during the fourth quarter. Envestnet Asset Management Inc. now owns 7,630,307 shares of the company's stock worth $72,793,000 after purchasing an additional 58,444 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in Haleon by 18.3% during the fourth quarter. JPMorgan Chase & Co. now owns 6,014,903 shares of the company's stock worth $57,382,000 after purchasing an additional 930,701 shares during the last quarter. Finally, Northern Trust Corp boosted its holdings in Haleon by 27.7% during the fourth quarter. Northern Trust Corp now owns 5,412,542 shares of the company's stock worth $51,636,000 after purchasing an additional 1,172,931 shares during the last quarter. Institutional investors own 6.67% of the company's stock.

Analyst Ratings Changes

Several analysts have commented on the stock. Wall Street Zen lowered shares of Haleon from a "buy" rating to a "hold" rating in a research report on Saturday, July 12th. Barclays reaffirmed an "overweight" rating on shares of Haleon in a report on Tuesday, May 6th. BNP Paribas raised shares of Haleon to a "strong-buy" rating in a report on Tuesday, May 27th. Morgan Stanley raised shares of Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 price objective for the company in a report on Friday, May 9th. Finally, BNP Paribas Exane raised shares of Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 price objective for the company in a report on Tuesday, May 27th. Six equities research analysts have rated the stock with a hold rating, four have issued a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat, Haleon currently has a consensus rating of "Moderate Buy" and a consensus target price of $12.33.

Haleon Trading Down 1.9%

Shares of HLN stock traded down $0.19 on Monday, hitting $9.48. 5,509,652 shares of the company's stock traded hands, compared to its average volume of 13,280,683. The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.78 and a current ratio of 0.98. Haleon PLC Sponsored ADR has a one year low of $8.86 and a one year high of $11.42. The company's fifty day simple moving average is $10.37 and its 200 day simple moving average is $10.20. The stock has a market capitalization of $42.56 billion, a price-to-earnings ratio of 24.32, a P/E/G ratio of 2.79 and a beta of 0.23.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.